Humanigen Logo

  • About Humanigen

    • Our Team
    • Business Development
    • Q&A Video Series
    • Contact Us
    • Subsidiaries

  • Compassionate Use

  • Publications

  • COVID-19

    • COVID-19 Resources
    • Map of Clinical Trial Sites

  • Cytokine Storm

    • The Myeloid Inflammatory Factor
    • Clinical Evidence
    • Driving The Storm
    • Timely Intervention

  • Our Programs

    • Pipeline
    • Industry Overview
    • Lenzilumab Development

  • Investor Relations & Media

    • Overview
    • News
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Governance
    • Media Resources

  • More

    Use tab to navigate through the menu items.
    PRESS RELEASES

    Press releases have moved to our standalone Investor Relations website. Click here to view.

    ​

    To sign up for investor email alerts, click here.

    ​

    Back to home page

    Follow Us

    • Twitter
    • LinkedIn
    • Facebook

    Terms Of Use | Privacy Policy | FAQ

    Contact Us | Careers

    ©2021 Humanigen, Inc.  All rights reserved